These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6125098)

  • 1. Withdrawal of beta-blocking drugs.
    Walden RJ; Hernandez J; Yu Y; Al-Khader A; Prichard BN
    Am Heart J; 1982 Aug; 104(2 Pt 2):515-20. PubMed ID: 6125098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-adrenergic blockade withdrawal phenomenon.
    Prichard BN; Tomlinson B; Walden RJ; Bhattacharjee P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S56-62. PubMed ID: 6188921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.
    Walden RJ; Bhattacharjee P; Tomlinson B; Cashin J; Graham BR; Prichard BN
    Br J Clin Pharmacol; 1982; 13(Suppl 2):359S-364S. PubMed ID: 6125188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
    Rangno RE; Langlois S
    Am Heart J; 1982 Aug; 104(2 Pt 2):473-8. PubMed ID: 7102534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
    Walden RJ; Tomlinson B; Graham B; Liu JB; Prichard BN
    Br J Clin Pharmacol; 1990 Oct; 30(4):557-65. PubMed ID: 1981318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
    Rangno RE; Langlois S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol.
    Wharrad HJ; Birmingham AT; Wilson CG; Williams EJ; Roland JM
    Br J Clin Pharmacol; 1984 Sep; 18(3):317-24. PubMed ID: 6487471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
    De Plaen JF; Amery A; Reybrouck T
    Eur J Clin Pharmacol; 1976 Sep; 10(5):297-303. PubMed ID: 789082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.
    Walden RJ; Tomlinson B; Graham B; Smith C; Betteridge DJ; Prichard BN
    Br J Clin Pharmacol; 1990 Oct; 30(4):547-56. PubMed ID: 1981317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
    Gilligan DM; Chan WL; Stewart R; Oakley CM
    Am J Cardiol; 1991 Sep; 68(8):766-72. PubMed ID: 1892084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors relating to the beta blocker withdrawal syndrome.
    Henderson A; Sheridan D; Ross J; Lewis M
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):25-8. PubMed ID: 6124208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.
    Kiyingi KS; Shaw J
    Eur J Clin Pharmacol; 1984; 27(4):423-8. PubMed ID: 6097455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal.
    Rangno RE; Langlois S; Stewart J
    Clin Pharmacol Ther; 1982 May; 31(5):564-71. PubMed ID: 7075106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.